Dear colleagues and friends,
As the novel coronavirus SARS-Cov-2 and the disease it causes, COVID-19, spread throughout the world, the safety and well-being of our community remain our top priority. I want to share that we are proactively working to keep our teams and scientists safe while also leading the fight against COVID-19.
The majority of our staff is now working remotely, and, keeping with the stay-at-home order, our faculty members are putting much of their experimental research on pause—with a few exceptions. Sumit Chanda, Ph.D., and his team of collaborators are working to test existing drugs for activity against SARS-Cov-2. If successful, this approach is likely the fastest avenue to an effective treatment against the virus.
Prior to the novel coronavirus outbreak, Chanda’s lab was advancing broad-spectrum antivirals—medicines that work against many viruses, not just one—that could protect us against a pandemic. Thus, he and his team are well positioned to laser-focus their efforts on COVID-19 at this unprecedented time.
I am hopeful that our work will emerge as part of the larger solution to this global health crisis. While we adjust to a lifestyle that we never planned for or imagined, we encourage you to stay safe and help protect your family, friends and community.
Kristiina Vuori, M.D., Ph.D.
Pauline and Stanley Foster Presidential Chair